Andrew R Clamp Selected Research

Andrew R Clamp Research Topics

Disease

18	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 06/2005
15	Carcinoma (Carcinomatosis) 01/2023 - 03/2005
12	Neoplasms (Cancer) 01/2023 - 06/2005
9	Ovarian Epithelial Carcinoma 10/2023 - 01/2019
2	Fatigue 05/2024 - 01/2023
2	Disease Progression 01/2020 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 11/2009
1	Fistula 05/2024
1	Anemia 01/2023
1	Nausea 01/2023
1	Fallopian Tube Neoplasms 02/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Proteinuria 05/2014
1	Hypertension (High Blood Pressure) 05/2014
1	Prostatic Neoplasms (Prostate Cancer) 02/2010
1	Neoplasm Metastasis (Metastasis) 11/2009
1	Pathologic Neovascularization 12/2006
1	Endometrial Neoplasms (Endometrial Cancer) 11/2005
1	Adenocarcinoma 06/2005

Drug/Important Bio-Agent (IBA)

16	PlatinumIBA 05/2024 - 01/2011
8	Paclitaxel (Taxol)FDA LinkGeneric 05/2024 - 02/2019
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 11/2005
7	Biomarkers (Surrogate Marker)IBA 11/2022 - 06/2005
6	Bevacizumab (Avastin)FDA Link 01/2023 - 09/2007
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2018
6	rucaparibIBA 12/2022 - 01/2020
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 12/2019
3	AntigensIBA 01/2023 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2023
2	olaparibIBA 01/2023 - 01/2023
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2020 - 10/2020
2	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 01/2018
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2005 - 06/2005
1	cediranib (AZD2171)IBA 05/2024
1	vistusertibIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	ParaffinIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2022
1	paragonIBA 10/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	pazopanib FDA Link 01/2020
1	fosbretabulin (combretastatin A4)IBA 01/2020
1	chemotactic factor inactivatorIBA 01/2020
1	Gemcitabine FDA Link 02/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	Angiogenesis InhibitorsIBA 05/2014
1	Hormones (Hormone)IBA 02/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2007
1	Sorafenib (BAY 43-9006)FDA Link 09/2007
1	Sunitinib (Sutent)FDA Link 09/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2005
1	OligosaccharidesIBA 11/2005
1	CytokinesIBA 06/2005
1	Heparitin Sulfate (Heparan Sulfate)IBA 06/2005
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 03/2005

Therapy/Procedure

17	Therapeutics 01/2023 - 09/2007
12	Drug Therapy (Chemotherapy) 05/2024 - 09/2007
2	Intravenous Infusions 01/2022 - 02/2019
2	Cytoreduction Surgical Procedures 01/2021 - 01/2020
2	Home Parenteral Nutrition 01/2020 - 12/2019
1	Retreatment 01/2023
1	Neoadjuvant Therapy 01/2021
1	Ligation 01/2019